PERITONEAL MESOTHELIOMA
Clinical trials for PERITONEAL MESOTHELIOMA explained in plain language.
Never miss a new study
Get alerted when new PERITONEAL MESOTHELIOMA trials appear
Sign up with your email to follow new studies for PERITONEAL MESOTHELIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New spray chemo combo shows promise for rare abdominal cancer
Disease control TerminatedThis study tests whether adding a special type of chemotherapy called PIPAC (sprayed directly into the abdomen) to standard IV chemotherapy can help people with peritoneal mesothelioma live longer. The trial includes 66 adults who have not had prior treatment and cannot have surg…
Matched conditions: PERITONEAL MESOTHELIOMA
Phase: PHASE2 • Sponsor: Institut du Cancer de Montpellier - Val d'Aurelle • Aim: Disease control
Last updated May 26, 2026 09:39 UTC
-
New hope for rare cancers: drug trial targets hard-to-treat tumors
Disease control TerminatedThis study tests a drug called XmAb20717 in 140 adults with advanced rare cancers, including mesothelioma, cervical cancer, and Hodgkin's lymphoma. The goal is to see if the drug can shrink tumors and how safe it is. Participants must have measurable disease and be able to follow…
Matched conditions: PERITONEAL MESOTHELIOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 18, 2026 12:01 UTC